Company Information
Ask for more detail from the seller
Contact SupplierPamidronate Disodium IV Infusion BP 30 mg & 60 mg is used in treatment of moderate to severe hypercalcemia associated with malignancy with or without bone metastases; treatment of moderate to severe Paget disease of bone; treatment of osteolytic bone lesions of multiple myeloma and bone metastases of breast cancer in conjunction with standard chemotherapy.
3s corporation is Supplier,Exporter ,Wholesaler for Pamidronate Disodium IV Infusion BP 30 mg & 60 mg in India.
India has many manufacturers who manufacture Pamidronate Disodium IV Infusion BP 30 mg & 60 mg .To know more contact us.
ADDITIONAL INFORMATION
Moderate to Severe Hypercalcemia of Malignancy
Adults
IV For moderate, give 60 to 90 mg as an initial single-dose infusion over 2 to 24 h. For severe, give 90 mg as an initial single-dose infusion over 2 to 24 h. For retreatment, same as initial therapy, at least 7 days after initial dose.
Paget Disease
Adults
IV 30 mg/day as a 4-h infusion on 3 consecutive days for a total dose of 90 mg. For retreatment, same as initial therapy, when clinically indicated.
Osteolytic Bone Metastases of Breast Cancer
Adults
IV 90 mg as a 2-h infusion every 3 to 4 wk.
Osteolytic Bone Lesions of Multiple Myeloma
Adults
IV 90 mg as a 4-h infusion on a monthly basis.
SIDE EFFECTS
Atrial fibrillation; atrial flutter; cardiac failure; hypertension; syncope; tachycardia.
CNSAsthenia; anxiety; fatigue; headache; insomnia; paresthesia; psychosis; somnolence.
DERMATOLOGICSweating.
ENDOCRINEHypothyroidism.
GIAbdominal pain; anorexia; constipation; diarrhea; dyspepsia; GI hemorrhage; nausea; stomatitis; vomiting.
GENITOURINARYUTI; uremia; renal toxicity.
HEMATOLOGIC-LYMPHATICAnemia; granulocytopenia; leukopenia; neutropenia; thrombocytopenia.
LAB TESTSHypocalcemia; hypokalemia; hypomagnesemia; hypophosphatemia.
LOCALInfusion-site reaction.
MUSCULOSKELETALArthralgia; arthrosis; back pain; bone pain; musculoskeletal pain; myalgia; osteonecrosis primarily of the jaws.
RESPIRATORYCoughing; dyspnea; pleural effusion; rales; rhinitis; sinusitis; upper respiratory infection.
MISCELLANEOUSEdema; fever; metastases; moniliasis; pain; allergic manifestations (eg, hypotension, dyspnea, angioedema, anaphylactic shock) .